Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Development of mRNA Vaccines for Infectious Diseases: Recent Updates
Nitika Nitika, Wei Jiao, Ai‐Min Hui
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 5271-5285
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

A Comprehensive Review of mRNA Vaccines
Vrinda Gote, Pradeep Kumar Bolla, Nagavendra Kommineni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2700-2700
Open Access | Times Cited: 200
A comprehensive comparison of DNA and RNA vaccines
Chunxi Wang, Fan Yuan
Advanced Drug Delivery Reviews (2024) Vol. 210, pp. 115340-115340
Closed Access | Times Cited: 20
A Multivalent mRNA Therapeutic Vaccine Exhibits Breakthroughs in Immune Tolerance and Virological Suppression of HBV by Stably Presenting the Pre-S Antigen on the Cell Membrane
Shang Liu, Jie Wang, Yunxuan Li, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 211-211
Open Access | Times Cited: 2
mRNA Vaccine Development for Emerging Animal and Zoonotic Diseases
Ting Le, Chao Sun, Jitao Chang, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 401-401
Open Access | Times Cited: 56
The Delivery of mRNA Vaccines for Therapeutics
Nitika Nitika, Wei Jiao, Ai‐Min Hui
Life (2022) Vol. 12, Iss. 8, pp. 1254-1254
Open Access | Times Cited: 54
Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery
Hezhi Wang, Qin Lu, Xin Zhang, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 970-993
Open Access | Times Cited: 48
Nanomaterials for mRNA‐based therapeutics: Challenges and opportunities
Defeng Li, Qisong Liu, Meifeng Yang, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 3
Open Access | Times Cited: 38
Lipid nanoparticles: The game-changer in CRISPR-Cas9 genome editing
Arezoo Mohammadian Farsani, Negin Mokhtari, Saghi Nooraei, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24606-e24606
Open Access | Times Cited: 13
Current Challenges of Vaccination in Fish Health Management
Avnish Kumar, Sushil Kumar Middha, Soumya V. Menon, et al.
Animals (2024) Vol. 14, Iss. 18, pp. 2692-2692
Open Access | Times Cited: 9
mRNA Technology in Modern Medicine: Review and Future Prospects
Heslley Machado Silva
Deleted Journal (2025) Vol. 2, pp. 1-1
Closed Access | Times Cited: 1
Vaccine development for bacterial pathogens: Advances, challenges and prospects
Ifeanyi Elibe, Hyelnaya Cletus Sharndama, Zikora Kizito Glory Anyaegbunam, et al.
Tropical Medicine & International Health (2023) Vol. 28, Iss. 4, pp. 275-299
Open Access | Times Cited: 21
CCHFV vaccine development, current challenges, limitations, and future directions
Büşra Ahata, Günseli Bayram Akçapınar
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 17
Precision-engineering of subunit vaccine particles for prevention of infectious diseases
Shuxiong Chen, Saranya Pounraj, Nivethika Sivakumaran, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
mRNA-based vaccine technology for HIV
Andra Fortner, Octavian Bucur
Discoveries (2022) Vol. 10, Iss. 2, pp. e150-e150
Open Access | Times Cited: 22
Respiratory Syncytial Virus Infection: Treatments and Clinical Management
Shiza Malik, Tahir Ahmad, Khalid Muhammad, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 491-491
Open Access | Times Cited: 12
The clinical progress and challenges of mRNA vaccines
Meng‐Zhen Yu, Nannan Wang, Jiaqing Zhu, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 15, Iss. 5
Closed Access | Times Cited: 11
The Platform Technology Approach to mRNA Product Development and Regulation
John Howard Skerritt, Carolyn Tucek-Szabo, Brett Sutton, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 528-528
Open Access | Times Cited: 4
Advancement in the development of mRNA‐based vaccines for respiratory viruses
Tays Troncoso-Bravo, Mario A. Ramírez, Ricardo A. Loaiza, et al.
Immunology (2024) Vol. 173, Iss. 3, pp. 481-496
Open Access | Times Cited: 4
Global Impact of hMPV Virus: Transmission, Pathogenesis, Diagnostic and Treatment
S Porwal, Rishabha Malviya, Sathvik Belagodu Sridhar, et al.
Diagnostic Microbiology and Infectious Disease (2025), pp. 116809-116809
Closed Access
mRNA vaccines against HIV: Hopes and challenges
Akmal Zubair, Hanbal Ahmad, Muhammad Arif, et al.
HIV Medicine (2025)
Closed Access
The Platform Technology Approach to mRNA Product Development and Regulation
John Howard Skerritt, Carolyn Tucek-Szabo, Brett Sutton, et al.
(2024)
Open Access | Times Cited: 3
mRNA vaccines against infectious diseases and future direction
Muhammad Tahir Aleem, Furqan Munir, Amna Shakoor, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112320-112320
Closed Access | Times Cited: 3
Challenges and advances of the stability of mRNA delivery therapeutics
Jingyi Zhai, Timothy R. Coté, Y Chen
Deleted Journal (2024) Vol. 01, Iss. 02, pp. 101-113
Open Access | Times Cited: 2
A prognostic insight of the mRNA vaccine against antibiotic-resistant bacteria
Mai Abdel Haleem Abusalah, Priyanka Choudhary, Hichem Bargui, et al.
Annals of Medicine and Surgery (2024)
Open Access | Times Cited: 1
Zoonosis and Vaccination for Fish Health Managment
Avnish Kumar, Sushil Kumar Middha, Soumya V. Menon, et al.
(2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top